809 PD2M Plenary Session Part 1, Expecting the Unexpected: Responses to Business Disruption in the Pharmaceutical Industry (Invited Talks)

Thursday, November 19, 2020: 9:00 AM - 10:00 AM
Pharmaceutical Discovery, Development and Manufacturing Forum (26) (vFairs Auditorium)

Description:
This plenary session is composed of a panel of representatives for addressing responses to business disruption in the pharmaceutical industry. Panelists will discuss approaches used to address COVID-19 disruptions and other emergency cases with an eye towards lessons learned for building greater business resilience. Topics span discovery, manufacturing, supply chain, regulatory practices and remote work.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Process Intensification & Modular Chemical Processing (T6B)
Chair:
Nima Yazdanpanah Email: nima@procegence.com
Co-chairs:
Blair Brettmann Email: blair.brettmann@mse.gatech.edu
Eric G. Moschetta Email: eric.moschetta@abbvie.com


9:00 AM
(81a) Continuous Revolutions: Distributed Manufacturing to Re-Shore the Pharmaceutical Supply Chain
Luke Rogers


9:10 AM
(81b) Building Resilient Supply Chains through the Manufacturing USA Institute Network
William Grieco


9:20 AM
(81c) Change Creates Opportunity and Disruptive Organizational Innovation
Brendon G. Ricart


9:30 AM
(81d) Responses to COVID-19 from Dow Life Sciences
Ida(Xue) Chen


9:40 AM
(81e) Social Distancing Via Telepresence for Product Development and Manufacturing
Jaquan Levons


9:50 AM
(81f) Innovation in Challenging Times
Gregory Frank
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>